Clinical Trials

NCT02880579 | COMPLETED
230 participants

Neurothrombectomy France

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-24
Start Date:
2013-05-31
Completion:
2015-03-31
Conditions
  • Cerebral Artery Occlusion
No Results Yet
NCT02838420 | COMPLETED | PHASE3
187 participants
NCT02593994 | ACTIVE_NOT_RECRUITING
4500 participants

IRIS-Onyx Cohort in the IRIS-DES Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-24
Start Date:
2015-10-31
Completion:
2027-12-31
Conditions
  • Coronary Artery Disease
  • Arterial Occlusive Diseases
  • Cardiovascular Diseases
  • Percutaneous Transluminal Angioplasty
Interventions
  • DEVICE
No Results Yet
NCT02581514 | COMPLETED | NA
53 participants

Eosinophilia Diagnosis

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-24
Start Date:
2015-10-31
Completion:
2019-09-30
Conditions
  • Hypereosinophilic Syndrome
Interventions
  • OTHER
No Results Yet
NCT02332980 | COMPLETED | PHASE2
65 participants

Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-24
Start Date:
2015-02-19
Completion:
2021-08-10
Conditions
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • Recurrent Chronic Lymphocytic Leukemia
  • Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Lymphoplasmacytic Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Nodal Marginal Zone Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
  • Recurrent Splenic Marginal Zone Lymphoma
  • Recurrent Waldenstrom Macroglobulinemia
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • Refractory Chronic Lymphocytic Leukemia
  • Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • Refractory Follicular Lymphoma
  • Refractory Lymphoplasmacytic Lymphoma
  • Refractory Nodal Marginal Zone Lymphoma
  • Refractory Small Lymphocytic Lymphoma
  • Refractory Splenic Marginal Zone Lymphoma
  • Refractory Waldenstrom Macroglobulinemia
  • Richter Syndrome
  • Waldenstrom Macroglobulinemia
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
NCT01989572 | COMPLETED | PHASE3
815 participants

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-24
Start Date:
2000-02-23
Completion:
2012-10-08
Conditions
  • Iris Melanoma
  • Medium/Large Size Posterior Uveal Melanoma
  • Mucosal Melanoma
  • Ocular Melanoma With Extraocular Extension
  • Recurrent Melanoma
  • Recurrent Uveal Melanoma
  • Small Size Posterior Uveal Melanoma
  • Stage IIA Cutaneous Melanoma AJCC v6 and v7
  • Stage IIA Uveal Melanoma AJCC v7
  • Stage IIB Cutaneous Melanoma AJCC v6 and v7
  • Stage IIB Uveal Melanoma AJCC v7
  • Stage IIC Cutaneous Melanoma AJCC v6 and v7
  • Stage IIIA Cutaneous Melanoma AJCC v7
  • Stage IIIA Uveal Melanoma AJCC v7
  • Stage IIIB Cutaneous Melanoma AJCC v7
  • Stage IIIB Uveal Melanoma AJCC v7
  • Stage IIIC Cutaneous Melanoma AJCC v7
  • Stage IIIC Uveal Melanoma AJCC v7
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Stage IV Uveal Melanoma AJCC v7
Interventions
  • OTHER
  • BIOLOGICAL
NCT01715402 | COMPLETED
3000 participants

Optimization of Health Expenditure in Liver Surgery

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-24
Start Date:
2012-09-30
Completion:
2015-09-30
Conditions
  • Hepatocellular Carcinoma
  • Hilar Cholangiocarcinoma
  • Intra Hepatic Cholangiocarcinoma
  • Liver Metastasis
Interventions
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page